Ex Parte Donoho et al - Page 5


                  Appeal 2004-1103                                                                                              
                  Application 09/733,387                                                                                        
                  detailed analysis of the Pb99-deficient mice will further elucidate the role of the                           
                  Pb99 protein in lymphocyte function and development . . .”  Id.  Thus, contrary to                            
                  appellants’ assertion, Sleckman does not functionally characterize Pb99 as a                                  
                  G protein-coupled receptor; instead, Sleckman expressly states that further                                   
                  research is necessary to elucidate the role of the Pb99 protein.                                              
                          In addition, regarding Sleckman’s recognition (page 4409, second column)                              
                  that Pb99 has seven distinct hydrophobic domains, suggesting that it may span                                 
                  the membrane seven times, we note that Ji teaches (page 17299, column 1),                                     
                  “there are putative seven transmembrane molecules, which do not appear to be                                  
                  coupled to a G protein.”  Accordingly, we are not persuaded by appellants’                                    
                  assertion that Sleckman functionally characterizes Pb99 as a                                                  
                  G protein-coupled receptor.                                                                                   
                          For the foregoing reasons, we disagree with appellants’ assertion “that the                           
                  present case directly tracks Example 10 of the Revised Interim Utility Guidelines                             
                  Training Materials . . . .”  Request, bridging sentence, pages 2-3, emphasis                                  
                  removed.   Unlike the facts in this case, the facts set forth in Example 10 of the                            
                  Training Materials establish that the sequence disclosed therein encodes a DNA                                
                  ligase which has a well-established use in the art.  On this record, there is no                              
                  evidence that the claimed sequence is a G protein-coupled receptor.  Further, for                             
                  the reasons set forth in the Decision, even if the claimed nucleic acid encodes a                             
                  G protein-coupled receptor, there is no disclosed utility for this receptor.  In this                         
                  regard, we note that claim 1 encompasses a 22 base pair fragment of SEQ ID                                    
                  No:43.  There is no evidence on this record that this 22 base fragment of SEQ ID                              
                  No:43 will encode a function protein.                                                                         
                          On reflection, for the reasons set forth above, in addition to those set forth                        
                  in the Decision, we reaffirm the rejection of claim 1 under 35 U.S.C. § 101 as                                
                  lacking utility and § 112, first paragraph, for lack of enablement based on the                               
                  finding of lack of utility.  Claims 2, 3 and 6-9 fall together with claim 1.                                  

                          We have carefully reviewed the original opinion in light of appellants’                               
                  request, but we find no point of law or fact which we overlooked or                                           


                                                               5                                                                


Page:  Previous  1  2  3  4  5  6  7  Next

Last modified: September 9, 2013